Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 220 - файл

.pdf
Скачиваний:
0
Добавлен:
28.08.2026
Размер:
86 Мб
Скачать
98
https://t.me/medicina_free
4 Acute Abdomen-Induced Preterm Labor
oxalate complex that is more soluble than cal­cium oxalate [203]. This role could be less important in pregnancy because pregnant women are twice as likely to have calcium phosphate stones than age-matched nonpregnant women and are two to three times more likely to have calcium phosphate stones than oxalate stones [204].
4.6.2.2 Progesterone
Adnexal Torsion/Ovariectomy
The tocolysis includes oral or IM progesterone in the rst trimester and oral or IV ritodrine in the second and third trimesters [205]. With the ovari­ectomy during the rst trimester, the patient should receive 17α-hydroxy progesterone capro­ate 250mgim. weekly for four weeks as proges­togen support for the pregnancy [206] and protection from uterine contractions and PTL.After this period, progesterone is produced by the placenta, and there is no need for its substitution.
There are no data about the specic inuence of isolated Fallopian tube torsion on uterine irri­tability during pregnancy. Therefore, prophylac­tic tocolysis is unnecessary and should be administered when uterine contractions are pres­ent [207].
Abdominal Trauma
Instead of magnesium sulfate, slow-released pro­gesterone should also be considered for uterine contractions after abdominal trauma in preg­nancy [208].
4.6.2.3 Anti-Inammatory Agents
NSAIDs/Indomethacin
Because bacterially induced PTL is associated with increased prostaglandin production, inhibit­ing the synthesis of prostaglandins is recom­mended in cases of (potential) infection-induced PTL. The administration of nonsteroidal anti­inammatory drugs (NSAIDs) curtails the pro­gression of both term labor and PTL [209, 210]. Currently used NSAIDs, such as indomethacin, block COX-1 and COX-2. Treatment with these
drugs is associated with fetal and maternal side effects that have precluded their use [209, 211]. Prostaglandin synthetase inhibitors were blamed for reversible closure/constriction of ductus arte­riosus, with minimal danger when used between 26 and 34 weeks of pregnancy [212, 213]. Although antenatal indomethacin may provide enough time for antenatal steroids to improve fetal maturation, these benets are associated with periventricular leukomalacia in premature infants [213]. The results also suggest that indo­methacin exposure within 72h before delivery is associated with necrotizing enterocolitis in pre­mature infants. Antenatal indomethacin is not associated with patent ductus arteriosus, respira­tory distress syndrome, bronchopulmonary dys­plasia, intraventricular hemorrhage, and mortality in premature infants. Also, no teratogenesis [188], altered hematological indices, or transient renal insufciency [214] were detected.
Observations indicate that COX-2-derived prostaglandins are important for bacterially induced PTL and that COX-2 is a potentially important target for stopping PTL [215]. There are still unresolved issues about the duration and the dosage of selective cyclooxygenase inhibitors on PTL.
One of the drawbacks of prostaglandin syn­thetase inhibitors is their anti-inammatory and antipyretic effect, which might mask the clinical presentation of the acute abdomen and give the surgeon a false sense of security. Therefore, it should be used once the diagnosis is established.
Experimental Anti-Inammatory Agents
The following sections consider some promising anti-inammatory agents potentially used to pre­vent infection-induced PTL.
NF-kB Inhibitors
N-acetylcysteine is a nonspecic free radical scavenger and NF-kB inhibitor, but is currently not in clinical use.
Sulfasalazine, a salicylate drug that blocks NF-kB activation by directly inhibiting the IKK kinases, is well tolerated and approved in preg­nancy, with no discernible increase in the risk of congenital fetal defects and morbidity or mortal-
4.6 Treatment
https://t.me/medicina_free
99
ity [216]. However, increased levels of chorionic apoptosis have been reported in a human mem­brane model, suggesting that prolonged treat­ment may result in eventual membrane degradation and loss of function and structural integrity [30]. Potential use with extrauterine, intraperitoneal (acute abdomen) -induced PTL is its short-course use in addition to antibiotics and infection source control.
TLR4 Antagonists
Inhibition using a monoclonal anti-TLR4 anti­body was effective in vivo in reducing pro­inammatory mediator (TNF-α, IL-8, and PGE2) production in amniotic uid [217] and the inci­dence of LPS-induced PTL [218]. Alternate TLR4 antagonists include eritoran tetrasodium [219] and TAK-242 [220], neither of which have been examined. TLR4 antagonism is only appropriate in cases of Gram-negative bacteria-induced PTL.
Anti TNF-α Antibodies
The complexity of cytokine interactions associ­ated with PTL suggests that targeting individual cytokines may not be the most optimal therapeu­tic intervention (Fig.4.11). Interestingly, mater­nal administration of these agents (iniximab) persists in the neonatal circulation for many weeks after birth [221] and may, therefore, dampen intrauterine and fetal inammation pro­tecting the fetus from the adverse sequelae of intrauterine infection and inammation. Also, these agents could be used for treating some of the causes of acute abdomen during pregnancy (Crohn's disease). There is little evidence for congenital abnormalities with anti-TNF-a ther­apy during pregnancy [222], but high levels in fetal circulation may increase the risk of neonatal infection. These facts should be weighed against the consequences of PTL caused by the acute abdomen.
Cytokine Suppressive Anti-Inammatory Drugs (CSAIDs)
CSAIDs target the NF-kB and p38 MAPK sig­naling pathways with demonstrated efcacy in animal models [223225]. These agents can be more effective and selective than NSAIDs in
inhibiting infection-induced PTL. They directly target signaling molecules without interfering with prostanoids' constitutive/homeostatic roles (Fig.4.12). Depending on the route of adminis­tration and placental transfer properties, CSAIDs may potentially block IAI and fetal inamma­tion, thereby protecting the fetus from the adverse sequelae of exposure to inammatory mediators.
Resveratrol
Resveratrol is a natural polyphenol capable of reducing LPS-induced PTL to 36% (versus 85% without the drug) and stillbirth to 34% (versus 62% without the drug) when administered orally to pregnant mice [227]. The suggested mecha­nism is the downregulation of the expression of pro-inammatory mediators such as iNOS and COX-2in macrophages and suppression of the production of eicosanoids such as prostaglan­dins. It was not tested on acute abdomen-induced PTL. Trans isoform should be avoided. The reduction in the DNA replication rate is one of the mechanisms by which trans-resveratrol impacts embryoid body development [228].
4.6.2.4 Betamimetics
Betamimetics are not indicated in patients with an acute abdomen. Ritodrine should not be used in a bowel obstruction or toxic megacolon due to its inuence on colonic dilation [229, 230].
4.6.3 Combination Treatment
4.6.3.1 Combination Tocolysis
It is unclear whether a combination of tocolytic drugs for PTL is superior to a single-agent tocol­ysis due to a lack of trials in patients with acute abdomen.
4.6.3.2 Tocolysis andNon-Tocolytic
Agents
There is only one study in non-acute abdomen patients. Using rigorous entry criteria, a thera­peutic cocktail of interventions, including antibi­otics, steroids, and tocolytics, demonstrated neonatal benet primarily by prolonging gesta­tion [231].
100
Tr iacyl
Diacyl
https://t.me/medicina_free
4 Acute Abdomen-Induced Preterm Labor
Flagellin
TLR5 TLR2-TLR1
Cytoplasm
Nucleus
Anti-TLR-4 antibodies
1
2
lipopeptides
MKKs
4
p38 MAPK
MSK1/2
CREB
IRAK1
2
lipopeptides
IRAK4
IRAK2
TRAF6
TAK1
CBP
3
4
LPS
TLR2-TLR6
IKKy
(NEMO)
IKKα IKKβ
P
IkB IkB
5
NF-kB
NF-kB
IKK complex inhibitors
P38 MAPK inhibitorsOxZnl
Degradation
1
TLR4
dsRNA
TLR3
IKK complex
Endosome
ssRNA
TLR7
IRAK4
IRAK1 IRAK2
TRAF3
3
P
Non-specific NF-kB inhibitors
5
TNF biologics
6
CpG DNA
TLR9
Pro-inflammatory cytokines
(IL-6, IL-8, IL-1β and TNF-α)
COX-2 expression
Matrix metalloproteinase
Myometrial contraction
Cervical ripening
Fetal membrane rupture
Preterm labour
6
Fig. 4.12 Infection-induced preterm labor triggered by activation of TLR-mediated NF-kB and p38 MAPK inammatory signaling cascades. Targets for the selected
A single antenatal course consists of 2×12mg betamethasone IM, 24h apart, or 4 × 6mg dexamethasone IM every 12h, after 24weeks of gestation.
The duration of fetal benet after a course of glucocorticoids is uncertain. A repeat course might confer a modest additional neonatal bene­t, whereas multiple courses can reduce fetal growth [232]. Benecial effects include a reduced rate of respiratory distress syndrome, intraven­tricular hemorrhage, neonatal death, necrotizing enterocolitis, patent ductus arteriosus, and bron­chopulmonary dysplasia [233].
In patients with acute abdomen, antibiotics are used as indicated for the underlying disease as prevention or treatment.
anti-inammatory agents are in red circles. (Reproduced with permission from [226] under the CC BY 4.0)
4.6.4 Placental Abruption Treatment
Immediate CS is indicated with a viable live fetus in traumatic-induced (See Sect. 25.3.6.1) and infection- induced placental abruption.
4.7 Prognosis
PTB ranges from 5% of births in European coun­tries to 18% in certain African countries [234]. It is the leading cause of childhood mortality in children under 5 years [235]. All-cause PTB accounts for 75% of perinatal mortality and more than half of long-term morbidity [236]. PTB has an increased risk of cognitive and neurological impairment, such as cerebral palsy and respira-
4.7 Prognosis
https://t.me/medicina_free
101
tory and gastrointestinal complications [4]. There is also an increased risk of chronic diseases in adulthood, such as obesity, diabetes, and hyper­tension [1]. Interestingly, premature males are at greater risk of mortality and neurological and respiratory morbidity when followed up at 2years of age [237].
Several critical questions remain unanswered: (1) the identication of a causative infectious agent(s), (2) the role of polymicrobial infection, (3) the critical locus of infection, 4) the burden of infection, and (4) the central immune cells and immune pathways.
Most premature infants exposed to one or more postnatal gram-negative bacteria or coagulase- negative staphylococci,
Staphylococcus aureus, and group B streptococ­cus are associated with an increased risk of cere-
bral palsy and adverse neurodevelopmental outcomes at 2years [238240]. Fetal bacteremia was found in 33% of fetuses with positive amni­otic uid cultures and 4% of those with negative amniotic uid cultures in the context of PPROM.Therefore, subclinical fetal infection is far more common than traditionally recognized. Recently, 23% of neonates born between 23 and 32 weeks of gestation had positive umbilical blood cultures for genital mycoplasmas [241].
The fetal mortality rate and the type of fetal morbidity differ between acute and (the type of) chronic maternal abdominal conditions. Acute abdominal conditions mainly result in spontane­ous abortion, stillbirth, or PTL, while chronic inammatory conditions result in congenital anomalies and PTL.Even acute abdominal con­ditions resemble chronic conditions if treated conservatively, which could result in recurrences with a chronic impact on the fetus.
4.7.1 Fetal Inammatory Response
Syndrome
4.7.1.1 Pathophysiology
Most fetuses exposed to chorioamnionitis develop a systemic inammatory response known as the fetal inammatory response syndrome (FIRS) [242, 243]. This is due to the fetus being
in direct contact with the infected amniotic uid or inammatory cell transfer from the uteropla­cental circulation. FIRS can be clinical or sub­clinical. Clinical FIRS is dened by a fetal plasma IL-6 >11pg/mL [244], while subclinical FIRS is dened histologically by funisitis and fetal vasculitis [243]. Fetuses with elevated plasma IL-6 had a higher rate of severe neonatal morbidity and a shorter cordocentesis-to-delivery interval than those with <11pg/mL.The disorder can also be diagnosed by measuring CRP in umbilical cord blood. Fetuses with FIRS have more systemic involvement, including hemato­logic abnormalities (neutrophilia) and a higher median nucleated red blood cell count than those without elevated IL-6. Also, fetal stress is deter­mined by the fetal plasma ratio of cortisol to dehydroepiandrosterone sulfate (DHEAS), con­genital fetal dermatitis, fetal cardiac dysfunction, involution of the thymus, and abnormalities of the fetal lung and brain. Among patients with PPROM, elevated fetal plasma IL-6 is associated with the impending onset of PTL, regardless of the inammatory state of the amniotic uid. This suggests that the human fetus plays a role in ini­tiating the onset of labor.
However, maternal-fetal cooperation must occur for parturition to be completed. Fetal inammation has been linked to the onset of labor associated with ascending intrauterine infection. However, systemic fetal inammation may occur in the absence of labor if the inam­matory process does not involve the chorioamni­otic membranes and decidua. Such instances may take place in the context of hematogenous viral infections or other disease processes (e.g., rhesus alloimmunization).
Affected fetuses have evidence of multiorgan involvement with a higher rate of severe neonatal morbidity after adjustment for gestational age, and PPROM results in a shorter cordocentesis-to­delivery interval. Neutrophilia is present in two­thirds of fetuses with FIRS, whereas neutropenia in 7%. FIRS is associated with BPD.The fetus can inhale amniotic uid and its contents which can reach the distal parts of the airways and the alveoli. FIRS is found in 76% of infants with atypical chronic lung disease, dened as chronic
102
https://t.me/medicina_free
4 Acute Abdomen-Induced Preterm Labor
lung disease without respiratory distress syn­drome. Bacterial products and cytokines may contribute to myocardial depression. Fetuses that cannot modify their cardiac compliance or main­tain ventricular cardiac output may suffer inade­quate brain perfusion, predisposing them to hypotension and brain ischemia in utero. This can result in periventricular leukomalacia and brain injury.
4.7.1.2 Prevention andTreatment
Treating maternal bacterial infection eliminates potentially inoculated bacteria in the fetus or amniotic uid. There is no effective treatment to prevent infection/inammation-related fetal brain injury. Prophylactic antibiotics given to mothers at risk of PTL who have ruptured mem­branes are still associated with an increased risk of fetal death and disability [245]. Killing bacte­ria will release even more inammatory bacterial fragments and, in addition to hypoxia and hyper­thermia, could result in brain injury despite pro­phylactic antibiotics.
Inhibitors of the IL-1RI decrease pro­inammatory cytokine IL-1β production, curbing the inammatory process. The commercially available drug anakinra (Kineret) competitively blocks the receptor and inhibits all its intracellu­lar pathways [246]. It protects the fetal brain from inammatory damage [247].
chorioamnionitis has enough time to develop in the acute abdomen. Also, cases of subclinical chorioamnionitis are missed resulting in an underestimation of this condition.
The risk of fetal death from maternal pyrexia, distinct from infection, may have been overstated [250]. Some drugs for treating severe infections may be teratogenic, thus compounding the effect of pyrexia. For effects of maternal pyrexia on fetal and neonatal development, see Sect. 4.7.3.
4.7.2.2 Fetal Trauma
See Chap. 5.
4.7.2.3 Placental Abruption
For fetal outcome from traumatic placental abruption, see Sect. 25.3.6.1. Neonates of the placental abruption with histologic chorioamnio­nitis group had increased neonatal adverse out­comes than the group with placental abruption from chronic vascular insufciency on the maternal- fetal interface [251]. No comparisons of placental abruptions exist between specic intra-abdominal infections or maternal abdomi­nal trauma. Placental abruption rate from specic acute abdominal causes is described in the chap­ters dealing with these conditions.
4.7.3 Fetal Morbidity
4.7.2 Fetal Mortality
4.7.2.1 Fetal Infection
In 1912, it was observed that the infection might extend to the uterus from the Fallopian tubes, the broad ligaments, and then from the uterine wall to the placenta [248]. With diffuse peritonitis, transplacental bacterial diffusion could result in intrauterine fetal death [249]. Fetal microbial invasion results in FIRS that can progress toward multiple organ dysfunction, septic shock, and death without timely delivery. Due to the small number of patients, it is difcult to compare the inuence of therapeutic delay, the type of micro­organism involved, and the proven route of infec­tion. It is questionable whether acute
The type of fetal morbidity partly depends on the cause of the maternal acute abdomen. There are three distinctive etiologic groups: (1) IAI, (2) bleeding, and (3) direct or indirect fetal trauma. Also, the presence of these etiologic groups makes both maternal and fetal prognoses worse. Fetal injuries common for all etiologic groups are described. For specic fetal traumatic injuries, see Chap. 5.
4.7.3.1 Brain Injury
Perinatal brain injuries, particularly cerebral palsy, periventricular leukomalacia, and intraven­tricular hemorrhage, are linked to intrauterine inammation [252254]. Exposure to histologi­cal chorioamnionitis combined with impaired placental perfusion increases the risk of poor
4.7 Prognosis
https://t.me/medicina_free
103
neurological and neurocognitive outcomes at 2years [255] and 8years [256] of corrected age in children born very preterm. Histological cho­rioamnionitis is also associated with increased speech delay and hearing loss at 18 months of corrected age in infants born very preterm [257]. Furthermore, histological chorioamnionitis caused by bacterial and viral infection has increased the risk of autism and schizophrenia [258]. Schizophrenia may result from post-acute latent inammation, whereas autism may be due to persistent inammation [258].
Several potential mechanisms could connect chorioamnionitis and adverse neurological out­comes. Intrauterine inammation is linked with diffuse white matter injury in the brain of preterm neonates due to TNF-α signaling and has been described as toxic to developing oligodendrocytes [124, 259, 260]. Chorioamnionitis has been asso­ciated with impaired fetal and newborn cardiac function [261, 262], which may compromise brain blood ow due to lower blood pressure [261, 263, 264]. This results in altered cerebral oxygen delivery. Impaired cerebral autoregulation is considered one of the main contributors to brain injury in preterm neonates [253, 265]. Impaired cerebral autoregulation may be more prevalent in neonates born after exposure to intrauterine inammation [264, 265]. Data from animal exper­iments are consistent with human studies in show­ing the effects of intrauterine inammation (with various routes of microbe inoculation) on the developing brain in the form of (1) karyorrhexis (nuclear fragmentation) of glial cells and reduced density and disorganization of white matter [266], (2) astrocytosis and a reduction in oligodendro­cyte number in subcortical white matter [267], (3) diffuse damage and focal periventricular leukom­alacia [268], and (4) decrease in myelination, potentially due to reduced numbers or function of oligodendrocytes [269]. Currently, it is unknown whether the: (a) location of the primary infective focus, (b) the route of infection dissemination, or (c) duration and severity of infection have differ­ent central nervous system (and other organs) consequences.
Women who experience abdominal trauma have an increased incidence of birth defects,
mostly damage/defects of the central nervous system, especially hydrocephaly [270, 271]. In 2 out of 7 blunt abdominal traumas, movement dis­orders and cerebral palsy were detected [270,
272].
Cerebral Palsy
Although previously described, in 1861, William John Little (Fig.4.13), an orthopedic, described the association of prematurity with cerebral palsy and the development of spastic diplegia. He hypothesized that, even without apparent exter­nal trauma, an inadequate supply of “oxygen and materials for nutrition” from the placenta to the fetus or an “insufcient removal of carbon and other residues” from the fetus through the pla­centa could lead to brain injury [273]. One-third of all neonates who later have signs of cerebral palsy weigh less than 2500 g. Newborns with birth weights less than 1500g have a rate of cere­bral palsy 25–31 times higher than those with normal birth weights. The most common form of cerebral palsy affecting preterm babies is spastic diplegia. In turn, preterm babies who develop spastic diplegia have a high rate of periventricu­lar leucomalacia.
Infection/Inammation
In 1955, Eastman and Deleon observed that intra­partum maternal fever was associated with a sev-
Fig. 4.13 William John Little ((1810–1894), an orthope­dic surgeon, lectured at the Obstetric Society of London and accentuated the association of prematurity with cere­bral palsy in Lancet in 1861. (Reproduced with permis­sion from [280])
104
https://t.me/medicina_free
4 Acute Abdomen-Induced Preterm Labor
enfold increase in the risk of cerebral palsy [274]. The prolonged temperature rise increases the metabolic rate and the oxygen requirements of the fast-developing tissues. When the demand out­strips the supply, placental efciency diminishes. Also, fast-growing tissues are especially suscep­tible to noxious stimuli [275]. For each degree of body temperature over 37°C, the oxygen required for tissue metabolism, including the brain, rises by 7%. Therefore, an intrapartum infection is a cause of cerebral palsy through the effects of bac­terial toxins and the mechanism of hypoxia/ anoxia. In 1977, chorioamnionitis increased the risk of cerebral palsy among low- birth weight infants from 12/1000 to 39/1000 live births [276].
Trauma
William Osler, who coined the term cerebral palsy, favored the hypothesis that trauma leading to meningeal hemorrhage and brain and spinal cord compression was a major cause of cerebral palsy [273]. The risk of cerebral palsy after MVA is 1.8/1000 [277]. MVAs during pregnancy may be associated with an increased risk of cerebral palsy in neonates with PTB [277]. Possible mechanisms for the association between preg­nancy trauma and cerebral palsy include reduced placental blood ow, placental embolization, and placental abruption. Kleihauer-Betke testing at the time of trauma and histological examination of the placenta at the delivery might clarify the role of placental separation [278]. The correla­tion between the type of cerebral palsy and maternal trauma during pregnancy is not clari­ed, but the spastic form is predominant in term infants [279]. In term babies, the type of MRI abnormality corresponds with the timing of the antenatal injury: trauma at 20 weeks results in extensive cortical dysplasia; trauma between 24 and 30 weeks results in periventricular white matter abnormality; trauma after 30weeks results in cystic encephalomalacia [279].
Epilepsy
Epilepsy is childhood's most common severe neurologic disorder [281283]. Before the age of 15, 1–1.7% of all children will have at least one unprovoked seizure, and up to 0.8% will have
repeated seizures [282]. The incidence of child­hood epilepsy is highest in the rst year of life— 150/100,000 person-years, falling to 50/100,000 person-years after the age of 9 [282].
Generalized epilepsies can often be traced to infection [282]. In particular, insults acting dur­ing the prenatal and to single-gene mutations or chromosomal abnormalities, while partial epilep­sies are frequently triggered by external insults to the central nervous system, including brain injury and central nervous system neonatal period, are thought to contribute to some types of epilepsies [281, 282, 284]. A seasonal pattern, i.e., an excess of births during winter months among children who develop epilepsy [285, 286], suggested pre­natal exposure to maternal infection may be a risk factor. Any maternal infection during preg­nancy (method of measurement unspecied) was associated with a 1.0- to 1.6-fold increase in the risk of childhood epilepsy [284]. Maternal self­reported history of cystitis, pyelonephritis, vagi­nal yeast infection, or symptoms of infection (diarrhea, coughs) during pregnancy was associ­ated with a 1.2- to 2.6-fold increased risk of epi­lepsy among offspring [287]. Risk varied by type of infection and was the highest for a self-reported vaginal yeast infection (2.6-fold) and pyelonephritis (2.3-fold) [287]. Therefore, a 40% increased risk of epilepsy is associated with pre­natal exposure to maternal systemic infection [288]. The infection could be caused by its ante­cedents, consequences, or antibiotic treatment. However, the similar magnitude of increased risk observed for different types of antibiotics argues against the role of specic types of infections or specic therapies. Various maternal infections, measured by self-report collected twice during pregnancy and 6 months after delivery, were associated with epilepsy in offspring [287].
Children with prenatal exposure to more than two maternal fever episodes, maternal fever with urinary symptoms, or maternal fever of 39 °C have an increased risk of epilepsy—suggesting that the underlying causes of fever rather than elevated temperature, such as sauna use, play a role [289]. Inammation may be involved in link­ing fever and epilepsy [290]. Inammatory reac­tions in the brain can enhance neuronal
4.7 Prognosis
https://t.me/medicina_free
105
excitability [291], and anti-inammatory treat­ments reduce seizures in experimental models.
Cytokines are key players in the modulation of neuronal excitability, leukocyte recruitment, and inammatory central nervous system infec­tions [290], yet their role in the pathogenesis of epilepsy is unclear. In response to infection dur­ing pregnancy, maternal cytokine production may induce fetal neurological injury [292]. A nearly threefold increased risk for epilepsy among children born to mothers with epilepsy suggests that infants genetically predisposed to epilepsy may be more susceptible to inamma­tory reactions [288].
Premature births result in 75% of neonatal deaths and most neonatal intensive care unit admissions [293]. A substantial effect of prema­ture birth on long-term physical and mental health is observed [294]. Babies born at <28weeks gestational age spend 85 times longer in the hospital than babies born at term [295]. Even among babies born after 32weeks, educa­tional and behavioral problems can occur in 33% at 7years of age [296], with 25% born between 32 and 35 weeks of gestational age requiring nonteaching assistants at school [297].
4.7.3.2 Lung Injury
IAI is also associated with lung injury. Elevated levels of TNF-α, IL-1β, IL-6, and IL-8 in the amniotic uid have been found in women who had babies with bronchopulmonary dysplasia (BPD), a chronic lung disease affecting infants. There are no data about fetal lung injury associ­ated with acute extrauterine IAI.
4.7.3.3 Low Gestational Weight
andBirth Defects
Low birthweight is associated with poor out­comes in cognitive function, academic achieve­ment, behavior, and social adaptation [298, 299]. Low birthweight is also associated with an increased risk of cardiovascular and chronic dis­eases [300].
Domestic Violence
Minor trauma during pregnancy may lead to the subclinical chronic placental disruption that per-
sists during pregnancy, which may cause an increase in the risk for induced abortion, acute placental abruption, PTL, PPROM, and placental insufciency that restricts fetal growth and lower Apgar score [301].
1/3 of the studies reported a positive associa­tion between intimate partner violence and low birth weight or PTB [302304]. Rates of low birth weight among battered women were 1.5–
2.5 times higher [302304] than those among nonbattered women, and rates of PTB were 2.5–4 times higher [302304]. Others lacked sufcient power to address most pregnancy outcomes [305,
306]. Many studies have reported increased rates
of low birth weight, reduction in mean birth weight, or PTL in bivariate analyses. However, the associations became nonsignicant when adjusted for tobacco use and other substances [307, 308].
Stratication by intention suggests three associations- longitudinal limb deciency, gas­troschisis, and hypoplastic left heart syndrome— possibly driven by intentionally inicted injuries [309]. The majority of intentional injuries result from intimate partner abuse, and these types of injuries could be more stressful for the mother [310].
Motor Vehicle Accidents
The estimation is that 9% of survivors of serious crashes develop signicant post-traumatic stress symptoms and that many other survivors have post-traumatic stress disorder-like reactions [311]. Associations have been observed between maternal stress during pregnancy, especially dur­ing the periconceptional period and conotruncal heart defects, interrupted aortic arch type B, atrioventricular septal defect, pulmonary atresia, tricuspid atresia, hypoplastic left heart syndrome, anorectal atresia/stenosis, longitudinal limb de­ciency, gastroschisis, neural tube defects [312,
313], and orofacial clefts [312, 313]. One should
be cautious with conclusions because there is a higher prevalence of alcohol and cigarette use during pregnancy among women who reported an intentional injury [310]. Alcohol and cigarette use during pregnancy is associated with an increased risk of birth defects [314, 315].
106
https://t.me/medicina_free
One thread suggests that stress, either very early in pregnancy or in the 24–28th weeks of pregnancy, leads to a twofold increase in the risk of autism [316]. Since autism is usually not apparent until 1–3years of age, it may be difcult to trace back to the primary events.
4.7.4 Maternal Outcome
In the late nineteenth century, maternal and fetal mortality from maternal diffuse peritonitis was 100% [130, 317].
4.7.4.1 Placental Abruption
Maternal mortality associated with all-cause pla­cental abruption decreased from 8% in 1919 to <1% in 1995 [318]. After placental abruption with a survived newborn, 59% of women had a subsequent delivery, compared with 71% of those without abruption. After the perinatal loss, the corresponding rates were 83 and 85% [319]. This may reect maternal anxiety and distress from further pregnancies caused by prior placental abruption. For trauma-induced placental abrup­tion outcomes, see Sect. 25.3.7.2.
4.7.4.2 Intrauterine Fetal Death
The issue with intrauterine fetal death is whether to deliver on an emergent basis by CS or wait for spontaneous delivery. The argument for late spon­taneous delivery is avoiding CS with all its poten­tial complications without benet for the dead fetus. On the contrary, intrauterine retention of a dead fetus for >5weeks may result in potentially hazardous hypobrinogenemia in 25% of patients. Prolonged retention is unusual since spontaneous delivery occurs within 3weeks of fetal death in >90% of patients [320]. If hypobrinogenemia develops, the onset is gradual. At least before the delivery, it may be asymptomatic or show clinical evidence of abnormal hemostasis, such as gingi­val bleeding or extensive ecchymoses. If hypo­brinogenemia develops, it persists until the uterus is emptied. Fibrinogen administration has a tran­sient effect and can result in hepatitis.
4 Acute Abdomen-Induced Preterm Labor
There is no indication for emergent delivery before 3weeks after fetal death, but not lon­ger than 5weeks [320] if there are no mater­nal indications for emergent delivery.
4.7.4.3 Intra-abdominal Infection
A CS due to IAI exposes the uterine wound to infection. This can result in endometritis, increas­ing the risk of opening the hysterorraphy [321]. Moreover, such uterine scars transform subse­quent pregnancies into high-risk pregnancies for uterine rupture.
References
1. Rubens CE, Sadovsky Y, Muglia L, Gravett MG, Lackritz E, Gravett C.Prevention of preterm birth: harnessing science to address the global epidemic. Sci Transl Med. 2014;6:262sr5.
2. Ananth CV, Vintzileos AM.Epidemiology of pre­term birth and its clinical subtypes. J Matern Fetal Neonatal Med. 2006;19:773–82.
3. WHO: Recommended denitions, terminology and format for statistical tables related to the perinatal period and use of a new certicate for cause of peri­natal deaths. Modications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand. 1977;56(3):247–53.
4. Goldenberg RL, Culhane JF, Iams JD, Romero R.Preterm birth 1: epidemiology and causes of pre­term birth. Lancet. 2008;371:75–84.
5. Romero R, Mazor M, etal. The preterm labor syn­drome. In: Elder MG, Romero R, Lamont RF, editors. Preterm Labor. New York: Churchill Livingstone;
1997. p.29–49.
6. Yuan M, Jordan F, McInnes IB, Harnett MM, Norman JE. Leukocytes are primed in peripheral blood for activation during term and preterm labour. Mol Hum Reprod. 2009;15:713.
7. Osman I, Young A, Jordan F, Greer IA, Norman JE.Leukocyte density and proinammatory media­tor expression in regional human fetal membranes and decidua before and during labor at term. J Soc Gynecol Investig. 2006;13:97.
8. Sfakianaki AK, Norwitz ER. Mechanisms of pro­gesterone action in inhibiting prematurity. J Matern Fetal Neonatal Med. 2006;19:763–72.
9. Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev. 2000;21:514–50.
References
https://t.me/medicina_free
107
10. Gareld RE, Sims S, Daniel EE.Gap junctions: their presence and necessity in myometrium during partu­rition. Science. 1977;198:958–60.
11. Gareld SM, Kannan MS, etal. Possible role of gap junctions in activation of myometrium during partu­rition. Am J Physiol. 1978;235:C168–79.
12. Balducci B, Gilula NB, etal. Gap junction formation in human myometrium: a key to preterm labor? Am J Obstet Gynecol. 1993;168:1609–15.
13. Orsino A, Taylor CV, Lye SJ. Connexin-26 and connexin-43 are differentially expressed and regu­lated in the rat myometrium throughout late preg­nancy and with the onset of labor. Endocrinology. 1996;137:1545–53.
14. Ou CW, Orsino A, Lye SJ.Expression of connexin-43 and connexin-26 in the rat myometrium during pregnancy and labor is differentially regulated by mechanical and hormonal signals. Endocrinology. 1997;138:5398–407.
15. Cook JL, Zaragoza DB, Sung DH, Olson DM. Expression of myometrial activation and stimula­tion genes in a mouse model of preterm labor: myo­metrial activation, stimulation, and preterm labor. Endocrinology. 2000;141(5):1718–28.
16. Lye SJ, Nicholson BJ, Mascarenhas M, MacKenzie L, Petrocelli T. Increased expression of connexin-43 in the rat myometrium during labor is associated with an increase in the plasma estrogen:progesterone ratio. Endocrinology. 1993;132(6):2380–6.
17. Petrocelli T, Lye SJ. Regulation of transcripts encoding the myometrial gap junction protein, connexin-43, by estrogen and progesterone. Endocrinology. 1993;133:284–90.
18. Lefebvre M, Bai XH, et al. Myometrial transcrip­tional regulation of the gap junction gene, connexin-
43. Reprod Fertil Dev. 1995;7:603–11.
19. Lye S. The initiation and inhibition of labour: Towards a molecular understanding. Semin Reprod Endocrinol. 1994;12:284–94.
20. Lye J, Nashman N, etal. Role of mechanical signals in the onset of term and preterm labor. Front Horm Res. 2001;27:165–78.
21. Shynlova A, Dorogin A, etal. Myometrial apopto­sis: activation of the caspase cascade in the preg­nant rat myometrium at midgestation. Biol Reprod. 2006;74:839–49.
22. Shynlova R, Lye SJ. Mechanical stretch regulates hypertrophic phenotype of the myometrium during pregnancy. Reproduction. 2010;139:247–53.
23. Shynlova JA, Tsampalieros A, et al. Progesterone and gravidity differentially regulate expression of extracellular matrix components in the pregnant rat myometrium. Biol Reprod. 2004;70:986–92.
24. Shynlova SJ, Draper H, etal. Uterine stretch regu­lates temporal and spatial expression of bronectin protein and its alpha 5 integrin receptor in myo­metrium of unilaterally pregnant rats. Biol Reprod. 2007;77:880–8.
25. Tattersall N, Khanjani S, et al. Pro-labour myome­trial gene expression: are preterm labour and term labour the same? Reproduction. 2008;135:569–79.
26. Olson DM, Ammann C. Role of the prostaglan­dins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour. Front Biosci. 2007;12:1329–43.
27. Korita D, Sagawa N, Itoh H, Yura S, Yoshida M, Kakui K, etal. Cyclic mechanical stretch augments prostacy­clin production in cultured human uterine myometrial cells from pregnant women: possible involvement of up-regulation of prostacyclin synthase expression. J Clin Endocrinol Metabol. 2002;87:5209.
28. Word RA, Li XH, Hnat M, Carrick K. Dynamics of cervical remodeling during pregnancy and par­turition: mechanisms and current concepts. Semin Reprod Med. 2007;25(1):69–79.
29. Winkler M, Rath W. Changes in the cervical extra­cellular matrix during pregnancy and parturition. J Perinat Med. 1999;27:45–60.
30. Keelan S, Yosaatmadja F, Mitchell MDJK.Prevention of inammatory activation of human gestational membranes in an ex vivo model using a phar­macological NF-kappa B inhibitor. J Immunol. 2009;183:5270–8.
31. Sakamoto P, Bulmer JN, et al. Macrophages and not granulocytes are involved in cervical ripening. J Reprod Immunol. 2005;66:161–73.
32. Hassan R, Haddad R, et al. The transcriptome of the uterine cervix before and after spontaneous term parturition. Am J Obstet Gynecol. 2006;195:778–86.
33. Sakamoto Y, Moran P, Searle RF, Bulmer JN, Robson SC. Interleukin-8 is involved in cervical dilatation but not in prelabour cervical ripening. Clin Exp Immunol. 2004;138(1):151–7.
34. Törnblom A, Bystrom B, etal. Non-infected preterm parturition is related to increased concentrations of IL-6, IL-8 and MCP-1in human cervix. Reprod Biol Endocrinol. 2005;3:39.
35. Roth T, Sorg C, etal. Phagocyte-specic S100 pro­teins: a novel group of proinammatory molecules. Trends Immunol. 2003;24:155–8.
36. Havelock P, Muleba N, et al. Human myometrial gene expression before and during parturition. Biol Reprod. 2005;72:707–19.
37. El Maradny E, Kanayama N, Halim A, Maehara K, Sumimoto K, Terao T.The effect of interleukin-1in rabbit cervical ripening. Eur J Obstet Gynecol Reprod Biol. 1995;60:75–80.
38. Chwalisz M, Scholz P, etal. Cervical ripening with the cytokines interleukin 8, interleukin 1 beta and tumour necrosis factor alpha in guinea-pigs. Hum Reprod. 1994;9:2173–81.
39. van der Burg B, van der Saag PT. Nuclear factor­kappa- B/steroid hormone receptor interactions as a functional basis of anti-inammatory action of steroids in reproductive organs. Mol Hum Reprod. 1996;2:433–8.